维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="Atadja"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	肠道菌群衍生的短链脂肪酸促进老年小鼠的脑卒中后恢复显示文摘老年人在脑卒中后经历了严重的全身反应,这导致了更高的死亡率和更严重的长期残疾。最近的研究表明,肠道微生物群的组成可以影响脑卒中的预后。然而,在损伤后肠道微生物群对预后影响的潜在益处尚不清楚。为了确定脑卒中后年轻肠道微生物是否有助于老年受试者的康复,研究者通过年轻粪便移植灌胃(young fecal transplant gavage,young FTG)改变了实验性脑卒中后老年小鼠的肠道微生物群。	刘青(译) 刘莉(摘/审校) Lee J d’Aigle J Atadja L	2020	中华高血压杂志2020，28，6：	12
2	Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells 显示文摘	EDWARDS A LI J ATADJA P	2007	Mol Cancer Ther2007，6，9：	1
3	Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824显示文摘	Atadja P Gao L Kwon P	2004	Cancer Res2004，64，2：	1
4	Epigeneties in cancer:targeting chromatin modifications显示文摘	Ellis L Atadja PW Johnstone RW		0，，：	1
5	Increased activity of p53 in senescing fibroblasts显示文摘	Atadja PH Wong H Garkavtsev I	1995	Proc Natl Acad Sci USA1995，92，：	1
6	The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation,oxidative injury,and the acid sphingomyelinase-dependent generation of ceramide显示文摘	Rosato RR Maggio SC Almenara JA Payne SG Atadja P Spiegel S	2006	Mol Pharmacol2006，69，1：	1
7	Epigenetics in cancer: targeting chromatin modifications 显示文摘	EllisL Atadja PW JohnstoneRW	2009	Mol Cancer Ther2009，6，8：	1
8	Epigenetics in cancer:targeting chromatin modifications显示文摘	Ellis L Atadja PW Johnstone RW	2009	Mol Cancer Ther2009，8，6：	1
9	Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells显示文摘	Edwards A Li J Atadja P	2007	Mol Cancer Ther2007，6，9：	1
10	Epigeneties in Cancer: tar- geting chromatin modifications 显示文摘	Ellis L Atadja PW Johnstone RW	2009	Mol Cancer Ther2009，8，6：	1
11	Inhibitors of human histone decetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates显示文摘	Remiszewski SW Sambucetti LC Atadja P	2002	J Med Chem2002，45，4：	1
12	Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824 显示文摘	Atadja P Hsu M Kwon P	2004	Novartis Found Symp2004，259，：	1
13	Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges 显示文摘	Atadja P	2009	Cancer Lett2009，280，2：	1
14	The novel histone deacetylase inhibitor LBH589 induces expression of DNA damage response genes and apoptosis in Ph-acute lymphoblastic leukemia cells 显示文摘	ANNA S KIRSCHBAUM M H ATADJA P et aI	2008	Blood2008，111，10：	1
15	Inhibitors of human hidtone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates 显示文摘	Remiszewski SW Sambucetti LC Atadja P	2002	J Med Chem2002，45，4：	1
16	Increased activity of p53 in senescing fibroblasts显示文摘	Atadja P Wong H Garkavtsev I	1995	Proc Natl Acad Sci USA1995，92，18：	1
17	Regulation of transcription factor activity during cellular aging显示文摘	Wheaton K Atadja P Riabowol K	1996	Biochem Cell Biol1996，74，：	1
18	Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells显示文摘	Edwards A Li J Atadja P	2007	Mol Cancer Ther2007，6，9：	1
19	In vitro and invivo rationale for the triple combination of panobinostat(LBH589) and dexamethasone with either bortezomib orlenalidomide in multipl-emyeloma 显示文摘	OCIO E M VILANOVA D ATADJA P	2010	Haematologica2010，95，5：	1
20	Epigeneties in cancer:tingeting chromatin modifications显示文摘	Ellis L Atadja PW Johnstone RW	2009	Mol Cancer Ther2009，8，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示